Aeon Biopharma Inc (AEON) Stock Price, Quote & News

Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceu...

Industry: Biotechnology

Sector: Healthcare

Phone: 949 354 6499

Website: www.aeonbiopharma.com

Address:

5 Park Plaza, Suite 1750, Irvine, United States

TWITLIEDETECTOR Dec. 5 at 3:57 AM

$AEON anyone out there? holding a small position. the lack of activity here makes me wonder

0 · Reply

ka1954 Dec. 4 at 8:33 PM

$AEON fucking company ruined it for the shareholders by announcing dilution a couple of weeks ago

1 · Reply

HalEugene Dec. 4 at 7:12 PM

$AEON Link for Corporate presentation if anyone didn’t receive and is interested. https://s25.q4cdn.com/951044395/files/doc_presentations/2025/12/AEON_Corporate-Presentation-12-3-25.pdf

0 · Reply

pm2024 Dec. 4 at 2:46 PM

$AEON Their corporate presentation looks impressing. I am bullish and will accumulate more if it gets to 0.70 range.

0 · Reply

TWITLIEDETECTOR Nov. 30 at 1:02 AM

$AEON support looks assuring

0 · Reply

TWITLIEDETECTOR Nov. 29 at 6:37 PM

$AEON a lot of resistance at $8. this actually could pop to $7 with a very strong PR hate pumpers but that’s from what i view on the chart. getting over $8 will not be easy. i actually agree with the analysts. i see where they get there numbers. makes sense i dont own any stock but i think will start to ease in on this.

0 · Reply

Mandi63 Nov. 26 at 8:43 PM

$AEON JANUARY 21st is FDA MEETING …WE HIT $1.40 WEEKS BEFORE LAST DATE OF FDA MEETING… UNDERVALUED AND LOW FLOAT… PRICE TARGET $7.00-15.00

0 · Reply

TraderManfromUK Nov. 26 at 8:25 PM

$AEON Waiting game until then expect it to barcode between 0.75 and 0.90 .. Boom time starts from Jan’26

1 · Reply

Salvadorspoppy Nov. 25 at 11:29 PM

$AEON .

0 · Reply

VinWeezel Nov. 25 at 10:55 PM

$AEON

0 · Reply

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

Nov 14, 2025, 8:30 AM EST - 20 days ago

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Nov 13, 2025, 8:30 AM EST - 21 days ago

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Oct 1, 2025, 8:00 AM EDT - 2 months ago

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

Aug 12, 2025, 4:05 PM EDT - 4 months ago

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

May 23, 2025, 4:05 PM EDT - 6 months ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

May 19, 2025, 4:05 PM EDT - 7 months ago

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

May 14, 2025, 4:05 PM EDT - 7 months ago

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 25, 2025, 4:05 PM EDT - 7 months ago

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Apr 21, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

Mar 27, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Announces CEO Transition

Mar 24, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 4, 2025, 8:00 AM EST - 9 months ago

AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

Feb 24, 2025, 2:00 PM EST - 10 months ago

AEON Biopharma, Inc. Announces Reverse Stock Split

Feb 7, 2025, 4:05 PM EST - 10 months ago

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Jan 7, 2025, 9:37 AM EST - 11 months ago

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

Jan 3, 2025, 8:02 PM EST - 11 months ago

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

Nov 13, 2024, 4:05 PM EST - 1 year ago

AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Aug 19, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

May 29, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan

May 14, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Provides Update on Development Pipeline

May 3, 2024, 7:00 AM EDT - 1 year ago

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine

Mar 30, 2024, 10:53 PM EDT - 1 year ago

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 4:15 PM EDT - 1 year ago

AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 3:45 PM EDT - 1 year ago

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 19, 2024, 4:30 PM EDT - 1 year ago

AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine

Mar 19, 2024, 4:29 PM EDT - 1 year ago

AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements

Jan 18, 2024, 4:05 PM EST - 2 years ago

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Dec 12, 2023, 8:00 AM EST - 2 years ago

AEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine

Nov 13, 2023, 8:15 AM EST - 2 years ago

AEON Biopharma Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:05 PM EDT - 2 years ago

AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

Aug 29, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Presents Positive Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia at the International Parkinson and Movement Disorders Society Congress®

Aug 24, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma

Jul 24, 2023, 7:00 AM EDT - 2 years ago

AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

TWITLIEDETECTOR Dec. 5 at 3:57 AM

$AEON anyone out there? holding a small position. the lack of activity here makes me wonder

0 · Reply

ka1954 Dec. 4 at 8:33 PM

$AEON fucking company ruined it for the shareholders by announcing dilution a couple of weeks ago

1 · Reply

HalEugene Dec. 4 at 7:12 PM

$AEON Link for Corporate presentation if anyone didn’t receive and is interested. https://s25.q4cdn.com/951044395/files/doc_presentations/2025/12/AEON_Corporate-Presentation-12-3-25.pdf

0 · Reply

pm2024 Dec. 4 at 2:46 PM

$AEON Their corporate presentation looks impressing. I am bullish and will accumulate more if it gets to 0.70 range.

0 · Reply

TWITLIEDETECTOR Nov. 30 at 1:02 AM

$AEON support looks assuring

0 · Reply

TWITLIEDETECTOR Nov. 29 at 6:37 PM

0 · Reply

Mandi63 Nov. 26 at 8:43 PM

$AEON JANUARY 21st is FDA MEETING …WE HIT $1.40 WEEKS BEFORE LAST DATE OF FDA MEETING… UNDERVALUED AND LOW FLOAT… PRICE TARGET $7.00-15.00

0 · Reply

TraderManfromUK Nov. 26 at 8:25 PM

$AEON Waiting game until then expect it to barcode between 0.75 and 0.90 .. Boom time starts from Jan’26

1 · Reply

Salvadorspoppy Nov. 25 at 11:29 PM

$AEON .

0 · Reply

VinWeezel Nov. 25 at 10:55 PM

$AEON

0 · Reply

Mandi63 Nov. 21 at 8:11 PM

$AEON This stock has been to a dollar and above several times this year…no reason it should be here ..very undervalued Lots of positives.. PRICE TARGETS $7.00-$15.00

0 · Reply

Azlvr Nov. 21 at 7:52 PM

$AEON 😵‍💫https://www.trustpilot.com/review/www.jccapitalconsultants.com

0 · Reply

Mandi63 Nov. 21 at 2:33 PM

$AEON January 21… Exciting New Year coming time for more institutional and inside buying .. Buy and Hold

0 · Reply

Otcgoblin Nov. 20 at 5:24 PM

$AEON see you at .60 like I already said….

0 · Reply

HalEugene Nov. 20 at 4:10 PM

$AEON The delay is due the Government shutdown. Federal employees who were furloughed returned to work last Thursday-they need time to catch up. The next potential shutdown is 01/30/2026 which will get AEON just in under the wire.

1 · Reply

TraderManfromUK Nov. 20 at 2:46 PM

$AEON FDA meeting now rescheduled to 26th Jan 2026.. meeting minutes / outcome will be on or before 30 days from 26th Jan

1 · Reply

VinWeezel Nov. 20 at 1:58 PM

$AEON https://www.stocktitan.net/news/AEON/aeon-biopharma-announces-first-closing-of-pipe-investment-and-ykjtut542zfp.html

0 · Reply

TWITLIEDETECTOR Nov. 20 at 6:05 AM

$AEON for a newcomer can someone please share the risks of this stock? seems pretty good. thank you

1 · Reply

Dfastpitchchic5 Nov. 19 at 11:49 PM

$AEON

0 · Reply

Moonster25 Nov. 19 at 8:52 PM

$AEON So everyone talking like today was the day, guess not. Waiting game? Might have to bow out on next spile, have to see if anything is said

1 · Reply

TraderManfromUK Nov. 19 at 8:38 PM

$AEON Both bulls and bears are unclear on the outcome hence price is staying almost at same levels … post today’s meeting .. minutes from FDA expected anytime within 30 days.. post which company will officially announce the outcome We might see a small spikes and dips due to this uncertainty Still bullish but only time will tell outcome 🫣

0 · Reply

Mckartt Nov. 19 at 5:35 PM

$AEON deep ownership on the inst. level

0 · Reply

Market Cap	9.35M
Revenue (ttm)	0.00
Net Income (ttm)	42.01M
EPS (ttm)	N/A
PE Ratio	0.30
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	147,800
Avg Vol	287,026
Day's Range	N/A - N/A
Shares Out	11.84M
Stochastic %K	28%
Beta	0.75
Analysts	Strong Sell
Price Target	$6.10